Clinical Trial Update: A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing zidovudine (AZT) alone versus AZT plus didanosine or AZT plus dideoxycytidine in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (didanosine)
• Dideoxycytidine (zalcitabine)
• Zidovudine (AZT) (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED